THE NTCP P.SER267PHE VARIANT IS ASSOCIATED WITH A FASTER ANTI-HBV EFFECT ON FIRST-LINE NUCLEOS(T)IDE ANALOG TREATMENT

The NTCP p.Ser267Phe Variant Is Associated With a Faster Anti-HBV Effect on First-Line Nucleos(t)ide Analog Treatment

Sodium taurocholate cotransporting polypeptide (NTCP) acts as a cellular receptor for the hepatitis B virus infection of host hepatocytes.Previously, many studies confirmed that the NTCP p.Ser267Phe variant was a protective factor against HBV-related disease progression.We therefore designed this study marni shirt green to investigate whether the N

read more